You are here

Levadex

MAP Pharma files NDA for migraine drug

Pharmaceutical Business Review

Fri, 05/27/11 - 09:04 am

MAP Pharmaceuticals

Allergan signs agreement with MAP Pharmaceuticals for LEVADEX

Tue, 02/1/11 - 05:15 pm

MAP Pharmaceuticals

Allergan and MAP Pharmaceuticals Announce Collaboration on LEVADEX(TM) Investigational Therapy for Acute Migraine

Trading Markets

Mon, 01/31/11 - 08:39 am

MAP Pharmaceuticals

Migraine Medication Developers Feeling No Pain

Minyanville

Thu, 09/9/10 - 05:50 pm

MAP Pharmaceuticals

Valeant Pharmaceuticals

MAP Pharmaceuticals reports positive study results for potential migraine treatment Levadex

Yahoo/AP

Thu, 09/9/10 - 06:32 am

MAP Pharmaceuticals

MAP shares rise on analyst view for migraine drug

Yahoo/AP

Mon, 06/15/09 - 07:40 pm

MAP Pharmaceuticals

MAP's Migraine Drug Provides Big Pain Relief

TheStreet.com

Tue, 05/26/09 - 09:46 am

MAP Pharmaceuticals

Pages